said Wednesday its Parkinson’s treatment failed in a midstage study. Sage stock collapsed to a record low. Wedbush analyst Laura Chico says it’s hard to tell whether the drug failed because of the drug, the goals of the study, the disease or a mix of all three. Sage is still testing that drug,…#wedbush #laurachico #huntington #barrygreene #chico #allisongatlin #ibdagatlin (Source: Reuters: Health)